Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Seres Therapeutics (MCRB) just unveiled an announcement.
Seres Therapeutics, Inc. has entered into an Asset Purchase Agreement with Nestlé’s subsidiary SPN, marking a significant move in the biopharmaceutical industry. Investors and interested parties can look forward to a conference call scheduled for August 6, 2024, at 8:30 a.m. Eastern Time, which will provide further details about this strategic transaction.
See more data about MCRB stock on TipRanks’ Stock Analysis page.